Literature DB >> 33148465

Management of corneal complications in vernal keratoconjunctivitis: A review.

Sepehr Feizi1, Mohammad Ali Javadi2, Mohammadhasan Alemzadeh-Ansari2, Amir Arabi2, Toktam Shahraki2, Ahmad Kheirkhah3.   

Abstract

Vernal keratoconjunctivitis (VKC) is a chronic, bilateral, allergic conjunctivitis with episodes of acute exacerbations. Although VKC has a self-limiting course, chronic recurrent inflammation can cause long-term visual impairment due to corneal complications including shield ulcers, infectious keratitis, keratoconus, corneal opacities, and limbal stem cell deficiency. The initial step in the management of corneal involvement is medical treatment of the acute stage of VKC and prevention of recurrences. Giant papillae not responding to medical treatment can be removed surgically in the case of corneal involvement. Shield ulcer with no inflammatory plaque usually heals with appropriate medical therapy. For shield ulcer with inflammatory plaque, however, surgical debridement with or without amniotic membrane transplantation might be necessary. Keratoconus may develop in chronic and severe VKC. An annual evaluation of these patients with corneal topography and/or tomography is essential for early detection of keratoconus and its timely management that includes collagen cross-linking and intrastromal corneal ring segment implantation. Corneal transplantation may be required in the advanced stage of keratoconus. Both penetrating keratoplasty and deep anterior lamellar keratoplasty can result in excellent visual outcomes in keratoconic eyes with concomitant VKC. Appropriate management of inflammation in the perioperative period is crucial for achieving successful outcomes after corneal transplantation. Limbal stem cell deficiency, a rare complication of long-standing and severe VKC, might be treated with living-related conjunctival limbal allograft.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Corneal complications; Corneal opacity; Keratoconus; Limbal stem cell deficiency; Management; Shield ulcer; Vernal keratoconjunctivitis

Mesh:

Year:  2020        PMID: 33148465     DOI: 10.1016/j.jtos.2020.10.005

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  5 in total

Review 1.  Systemic diseases and the cornea.

Authors:  Ruchi Shah; Cynthia Amador; Kati Tormanen; Sean Ghiam; Mehrnoosh Saghizadeh; Vaithi Arumugaswami; Ashok Kumar; Andrei A Kramerov; Alexander V Ljubimov
Journal:  Exp Eye Res       Date:  2021-01-21       Impact factor: 3.467

2.  Current and Emerging Therapies for Limbal Stem Cell Deficiency.

Authors:  Abdelrahman M Elhusseiny; Mohammad Soleimani; Taher K Eleiwa; Reem H ElSheikh; Charles R Frank; Morteza Naderan; Ghasem Yazdanpanah; Mark I Rosenblatt; Ali R Djalilian
Journal:  Stem Cells Transl Med       Date:  2022-03-31       Impact factor: 6.940

3.  Clinical, histological and immunohistochemistry characteristics of cornea in the sequelae stage of chronic vernal keratoconjunctivitis.

Authors:  Jilu Jaffet; Vivek Singh; Sunita Chaurasia; Saumya Jakati; Ajit Hazari; Virender Sangwan
Journal:  Indian J Ophthalmol       Date:  2022-01       Impact factor: 1.848

Review 4.  Epithelial barrier dysfunction in ocular allergy.

Authors:  Neera Singh; Yolanda Diebold; Srikant K Sahu; Andrea Leonardi
Journal:  Allergy       Date:  2021-11-28       Impact factor: 14.710

5.  Five years' retrospective analysis of childhood ocular morbidities: A priority setting guidelines for pediatric eye clinic.

Authors:  Sadia Bukhari; Shua Azam; Shahid Ahsan; Tauseef Mahmood; Muhammad Saleh Memon; Uzma Haseeb; Muhammad Arslan
Journal:  Pak J Med Sci       Date:  2022 Jul-Aug       Impact factor: 2.340

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.